FFA
ADMA icon

Farther Finance Advisors’s ADMA Biologics ADMA Stock Holding History

Farther Finance Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.9K Sell
3,181
-1,447
-31% -$13.4K ﹤0.01% 3780
2026
Q2 		$38.7K Sell
4,628
-7,204
-61% -$65.7K ﹤0.01% 3454
2026
Q1 		$108K Sell
11,832
-268
-2% -$4.23K ﹤0.01% 2458
2025
Q4 		$221K Buy
12,100
+2,690
+29% +$45.3K ﹤0.01% 1849
2025
Q3 		$138K Buy
9,410
+2,214
+31% +$38K ﹤0.01% 1838
2025
Q2 		$131K Buy
7,196
+4,473
+164% +$91.2K ﹤0.01% 1612
2025
Q1 		$52.9K Buy
2,723
+2,505
+1,149% +$43.3K ﹤0.01% 1869
2024
Q4 		$3.74K Buy
218
+5
+2% +$94 ﹤0.01% 2780
2024
Q3 		$4.26K Buy
213
+193
+965% +$3K ﹤0.01% 2706
2024
Q2 		$231 Hold
20
– – ﹤0.01% 3470
2024
Q1 		$131 Buy
20
+10
+100% +$55 ﹤0.01% 3333
2023
Q4 		$45 Buy
+10
New +$37 ﹤0.01% 3390

Other funds holding ADMA

CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's ADMA Position: Q3 2026 in Review

Farther Finance Advisors reduced its ADMA Biologics (ADMA) stake by 31% in Q3 2026, selling an estimated $13.4K and leaving 3,181 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Farther Finance Advisors first reported a position in ADMA in Q4 2023 and has held it in 12 quarters since. The position peaked at $221K in Q4 2025. 11 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Farther Finance Advisors held 3,181 shares of ADMA Biologics worth $31.9K as of Q3 2026.
  • Farther Finance Advisors sold 1,447 ADMA Biologics shares in Q3 2026, an estimated $13.4K.
  • ADMA Biologics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3780 holding.
  • Farther Finance Advisors first reported a position in ADMA Biologics in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's ADMA Biologics position peaked at $221K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.